Orchestra BioMed: Sherman proposes 15,000-share sale

The notice also lists three earlier sales of 15,000 shares each during the preceding three months.

Rhea-AI Filing Summary

Orchestra BioMed Holdings, Inc. (OBIO) reports that Darren Sherman proposes to sell 15,000 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $94,050.00 and an approximate sale date of October 1, 2026. The notice lists three sales during the preceding three months: 15,000 shares on July 1, 2026, for $64,066.02; 15,000 shares on August 3, 2026, for $61,291.68; and 15,000 shares on September 1, 2026, for $74,059.38. The shares proposed for sale are described as acquired through restricted stock vesting on November 25, 2024.

Key Figures

Proposed shares for sale: 15,000 shares Aggregate market value: $94,050.00 Shares sold: 15,000 shares +5 more

8 metrics

Proposed shares for sale 15,000 shares Common shares; approximate sale date October 1, 2026

Aggregate market value $94,050.00 Proposed sale

Shares sold 15,000 shares July 1, 2026

Reported amount $64,066.02 Sale on July 1, 2026

Shares sold 15,000 shares August 3, 2026

Reported amount $61,291.68 Sale on August 3, 2026

Shares sold 15,000 shares September 1, 2026

Reported amount $74,059.38 Sale on September 1, 2026

Key Terms

Rule 144, Restricted Stock Vesting, attorney-in-fact

3 terms

Rule 144 regulatory

"the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Common | 11/25/2024 | Restricted Stock Vesting"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for Darren Sherman"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many OBIO shares does Darren Sherman plan to sell?

Darren Sherman proposes to sell 15,000 common shares, with an aggregate market value of $94,050.00 and an approximate sale date of October 1, 2026. Fidelity Brokerage Services LLC is listed in connection with the sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/01/2026 - 10:37 AM Accepted by SEC EDGAR 10/01/2026 - 10:37 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001723524
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Orchestra BioMed Holdings, Inc.
SEC File Number	001-39421
Address of Issuer	150 UNION SQUARE DRIVE NEW HOPE PENNSYLVANIA 18938
Phone	646-343-9298
Name of Person for Whose Account the Securities are To Be Sold	Sherman Darren
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	15000	94050.00	60105049	10/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/25/2024	Restricted Stock Vesting	Issuer			15000	11/25/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Darren Sherman 150 Union Square Drive New Hope PA 18938	Common	07/01/2026	15000	64066.02
Darren Sherman 150 Union Square Drive New Hope PA 18938	Common	08/03/2026	15000	61291.68
Darren Sherman 150 Union Square Drive New Hope PA 18938	Common	09/01/2026	15000	74059.38

144: Remarks and Signature

Remarks
Date of Notice	10/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/18/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Margaret Campbell, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Darren Sherman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)